Virios Therapeutics, Inc. (VIRI)
NASDAQ: VIRI · IEX Real-Time Price · USD
0.234
+0.012 (5.41%)
At close: Jul 2, 2024, 4:00 PM
0.237
+0.003 (1.28%)
After-hours: Jul 2, 2024, 7:56 PM EDT

Virios Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018
Net Income
-5.3-12.25-15.96-10.35-2.47
Upgrade
Share-Based Compensation
0.620.580.327.430
Upgrade
Other Operating Activities
-0.190.2-0.05-0.980.38
Upgrade
Operating Cash Flow
-4.87-11.47-15.69-3.9-2.09
Upgrade
Share Issuance / Repurchase
1.164.49-0.131.530
Upgrade
Debt Issued / Paid
0001.932.37
Upgrade
Other Financing Activities
----0.08-
Upgrade
Financing Cash Flow
1.164.49-0.133.382.37
Upgrade
Net Cash Flow
-3.71-6.98-15.7929.490.28
Upgrade
Free Cash Flow
-4.87-11.47-15.69-3.9-2.09
Upgrade
Free Cash Flow Per Share
-0.26-1.04-1.88-0.79-0.43
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).